Kesin Mag-Al Plus Xs

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the relief of symptoms associated with acid indigestion, heartburn, sour stomach, and upset stomach due to these conditions. Additionally, it is effective in alleviating pressure and bloating commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use to ensure proper mixing of the formulation.

For adults and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls administered four times a day, or as directed by a physician. It is important to note that the maximum dosage should not exceed 16 teaspoonfuls within a 24-hour period, and this maximum dosage should not be used for more than 2 weeks.

For children under 12 years of age, it is advised to consult a physician for appropriate dosing recommendations.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion or misuse.

• If symptoms persist for more than 2 weeks, discontinue use and consult a healthcare professional for further evaluation.

Warnings and Precautions

Patients should not exceed a maximum dosage of 16 teaspoonfuls within a 24-hour period, nor should they utilize the maximum dosage for longer than 2 weeks unless under the guidance and supervision of a physician.

Healthcare professionals are advised to exercise caution and recommend that patients consult a physician prior to use if they have a history of kidney disease or are on a magnesium-restricted diet. Additionally, it is prudent to advise patients to seek guidance from a doctor or pharmacist if they are currently taking any prescription medications, as antacids may interact with certain drugs.

Patients should be instructed to discontinue use and contact their healthcare provider if symptoms persist beyond 2 weeks.

In the event of an overdose, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. Serious warnings include the recommendation not to exceed 16 teaspoonfuls in a 24-hour period and not to use the maximum dosage for more than 2 weeks without the advice and supervision of a physician.

Patients with kidney disease or those on a magnesium-restricted diet should consult a doctor prior to use. Additionally, it is advisable for patients to seek guidance from a healthcare professional if they are currently taking a prescription drug, as antacids may interact with certain medications.

Patients are advised to discontinue use and consult a doctor if symptoms persist for more than 2 weeks. It is crucial to keep this medication out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

Antacids, specifically those containing aluminum and magnesium hydroxide, may interact with certain prescription medications. This interaction can potentially alter the absorption and efficacy of these drugs. It is advisable for healthcare professionals to monitor patients closely when these antacids are co-administered with other medications, and to consider adjusting the timing of administration to minimize any impact on drug absorption.

No additional drug interactions or laboratory test interactions have been reported.

Packaging & NDC

Below are the non-prescription pack sizes of Kesin Mag-Al Plus Xs (aluminum and magnesium hydroxide w/simethicone suspension). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician before use. For adolescents and adults aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls four times a day or as directed by a physician.

Geriatric Use

Elderly patients should consult a physician prior to use if they have a history of kidney disease or if they are on a magnesium-restricted diet.

For adults and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls four times a day, or as directed by a healthcare provider. It is important to note that for children under 12 years of age, a physician should be consulted for appropriate dosing recommendations.

Healthcare providers should exercise caution when prescribing this medication to geriatric patients, ensuring that any underlying health conditions are taken into account and that appropriate monitoring is conducted throughout the treatment period.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have a history of kidney disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be vigilant in monitoring for symptoms that may arise from an overdose. While specific symptoms are not detailed in the provided information, it is essential to assess the patient for any signs of toxicity or distress.

Management of an overdose should be guided by established protocols, which may include supportive care and symptomatic treatment as necessary. Continuous evaluation of the patient's condition is recommended to ensure appropriate interventions are implemented in a timely manner.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if their symptoms persist for more than two weeks. It is also important for healthcare providers to recommend that patients consult a doctor before using the medication if they have kidney disease or are on a magnesium-restricted diet.

Additionally, patients should be encouraged to speak with their doctor or pharmacist prior to use if they are currently taking any prescription medications, as antacids may interact with certain drugs.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F). Care must be taken to avoid freezing, as this may compromise the integrity of the product. Proper container requirements should be adhered to, ensuring that the product is kept in a suitable environment to maintain its efficacy. Special handling needs should be observed to ensure optimal storage conditions are met.

Additional Clinical Information

The medication is administered orally. Clinicians should counsel patients to consult a healthcare professional if they are pregnant or breastfeeding before use. Patients with kidney disease or those on a magnesium-restricted diet should also seek medical advice prior to administration. Additionally, it is important for patients to inform their doctor or pharmacist if they are currently taking any prescription medications, as antacids may interact with certain drugs. Patients are advised to discontinue use and consult a doctor if symptoms persist for more than two weeks.

Drug Information (PDF)

This file contains official product information for Kesin Mag-Al Plus Xs, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)